CN1078905A - A kind of medicine for external use for the treatment of hepatopathy - Google Patents
A kind of medicine for external use for the treatment of hepatopathy Download PDFInfo
- Publication number
- CN1078905A CN1078905A CN 93110361 CN93110361A CN1078905A CN 1078905 A CN1078905 A CN 1078905A CN 93110361 CN93110361 CN 93110361 CN 93110361 A CN93110361 A CN 93110361A CN 1078905 A CN1078905 A CN 1078905A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine
- external use
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is a kind of medicine for external use for the treatment of hepatopathy, is made up of antipyretic and antidotal type Chinese medicine, medicine, liver-smoothing, qi-regulating class Chinese medicine, warming YANG class Chinese medicine, the class of having one's ideas straightened out Chinese medicine.The Chinese crude drug processing powder is broken into smalls, makes medicated cushion, directly acts on the body surface position of liver, and good penetrability, the efficacy of a drug are concentrated, and hepatopathys such as the depression of liver-QI of treatment hepatitis and traditional Chinese medical science indication, stagnation of liver-QI are had curative effect preferably.
Description
The invention belongs to the Chinese medicine class, be a kind of medicine for external use for the treatment of hepatopathy.
At present, Western medicine does not still have the specific treatment method to viral hepatitis.Chinese medicine is to the depression of liver-QI of hepatitis and traditional Chinese medical science indication, and hepatopathys such as liver what have significantly curative effect, yet traditional oral medication method is a systemic administration, and systemic administration target organ drug level is low, affects the treatment; Oral medication also has zest to gastrointestinal tract, and patient is difficult to tolerate the normal phase and takes medicine; The decocting dosage form, the process of boiling medicine complexity is taken inconvenience, because these deficiencies have influenced the use and the curative effect of medicine.
The objective of the invention is to inner disease outer treat, a kind of medicine for external use is provided, directly act on the body surface position of liver, hepatoprotective is treated liver diseases such as hepatitis effectively.
The objective of the invention is to realize in the following manner:
The medicine for external use of treatment hepatopathy is by antipyretic and antidotal type Chinese medicine, invigorating blood circulation what class Chinese medicine, liver-smoothing, qi-regulating class Chinese medicine, warming YANG class Chinese medicine, the class of having one's ideas straightened out Chinese medicine composition.
Purpose of the present invention can also realize in the following manner:
The medicine for external use of treatment hepatopathy, by weight, by the antipyretic and antidotal type Chinese medicine of 6-66%, the invigorating blood circulation what class Chinese medicine of 8-40%, the liver-smoothing, qi-regulating class Chinese medicine of 12-30%, the warming YANG class Chinese medicine of 8-48%, the 2-4% class Chinese medicine of having one's ideas straightened out is formed, and the preferred value of each constituent is: antipyretic and antidotal type Chinese medicine 18-42%, invigorating blood circulation what class Chinese medicine 8-40%, liver-smoothing, qi-regulating class Chinese medicine 12-30%, warming YANG class Chinese medicine 12-28%, the class of having one's ideas straightened out Chinese medicine 2-4%.
Antipyretic and antidotal type Chinese medicine can be selected the 4-6 kind from following Chinese medicine: Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci or Herba Houttuyniae, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae, preferably form by Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci or Herba Houttuyniae, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae, compositing range respectively is 1-11%, and preferred value is 3-7%.There is Herba Taraxaci can not have Herba Houttuyniae in the prescription, has Herba Houttuyniae can not have Herba Taraxaci, also can have simultaneously by two kinds of Chinese medicines.
Invigorating blood circulation what class Chinese medicine can be selected the 5-8 kind from following Chinese medicine: Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae or Herba Lycopi, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae.Preferably be made up of Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae or Herba Lycopi, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae, compositing range respectively is 1-5%.Radix Salviae Miltiorrhizae and Herba Lycopi can replace mutually, also can two kinds all add in the prescription.
Liver-smoothing, qi-regulating class Chinese medicine can be selected the 4-6 kind from following Chinese medicine: Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae, compositing range are 2-5%.
Warming YANG class Chinese medicine can be selected the 2-4 kind from following Chinese medicine: Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi or Ramulus Cinnamomi.Preferably be made up of Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi or Ramulus Cinnamomi, compositing range respectively is 2-12%, and preferred value is 3-7%.
The class of having one's ideas straightened out Chinese medicine can be selected the 1-2 kind from following Chinese medicine: Rhizoma Acori Graminei, Borneolum Syntheticum, preferably to form by Rhizoma Acori Graminei, Borneolum Syntheticum, and compositing range respectively is 1-2%.
Chinese crude drug processing powder of the present invention is broken into smalls, evenly is sprinkling upon on the multilamellar gauze, and sewing it up is medicated cushion, and medicated cushion acts on liver body surface position, as makes vest, makes interlayer and stays mouth at the position, hepatic region, is the vest that can treat hepatopathy behind the placement medicated cushion.General drug effect continues about one month.
Advantage of the present invention: medicine directly acts on the body surface position good penetrability of liver, the efficacy of a drug is concentrated, improve than the systemic administration curative effect, removed the complex process of water decoction type, avoided oral drugs that gastrointestinal is stimulated, for the symptom of improving hepatitis patient and sign, recovering liver function is significantly improved than simple liver protecting therapy, has the adjusting vegetative nerve function, strengthened body immunity, enliven liver microcirculation, promote the reparation and the regeneration of liver, hepatopathys such as the depression of liver-QI of treatment hepatitis and traditional Chinese medical science indication, liver what are had curative effect preferably.
Clinical case:
With * *, woman, 35 years old, the workman of Boshan rubber plant, trouble hepatitis year is surplus, and the patient is surplus February through hospitalization, after leaving hospital, improvement still feels weak, liver pain discomfort, poor appetite, though it is still not obvious that routine is taken the hepatic effect, after wear the medicinal vest that the present invention makes, liver pain alleviates after 5 months, fade away, food is received increases thereupon, weak alleviating, state of an illness consolidation.
Embodiment one:
The present invention is made up of following medicine:
Herba Pogostemonis 1%, Herba Eupatorii 3%, Herba Taraxaci 7%, Herba Artemisiae Scopariae 11%, Rhizoma Atractylodis 5%, the Radix Stemonae 2%, Rhizoma Chuanxiong 1%, Rhizoma Curcumae 3%, Flos Carthami 5%, Radix Salviae Miltiorrhizae 4%, Radix Angelicae Sinensis 1%, Radix Curcumae 2%, Rhizoma Corydalis 3%, Rhizoma Curcumae Longae 5%, Herba Artemisiae Anomalae 2%, the Radix Aucklandiae 5%, Fructus Amomi 4%, Pericarpium Citri Reticulatae Viride 3%, roud cardamon seed 2%, Pericarpium Citri Reticulatae 5%, Rhizoma Alpiniae Officinarum 3%, Fructus Evodiae 11%, Flos Caryophylli 2%, Cortex Cinnamomi 7%, Rhizoma Acori Graminei 2%, Borneolum Syntheticum 1%.
The said medicine processing powder is broken into smalls, evenly is sprinkling upon on the multilamellar gauze, around fixedly being medicated cushion, makes vest with sewing machine, puts into medicated cushion at the position, hepatic region.
Embodiment two:
Herba Pogostemonis 11%, Herba Eupatorii 5%, Herba Taraxaci 1%, Herba Artemisiae Scopariae 1%, Rhizoma Atractylodis 7%, the Radix Stemonae 11%, Rhizoma Chuanxiong 5%, Rhizoma Curcumae 1%, Flos Carthami 1%, Radix Salviae Miltiorrhizae 2%, Radix Angelicae Sinensis 3%, Radix Curcumae 5%, Rhizoma Corydalis 1%, Rhizoma Curcumae Longae 3%, Herba Artemisiae Anomalae 5%, the Radix Aucklandiae 2%, Fructus Amomi 2%, Pericarpium Citri Reticulatae Viride 5%, roud cardamon seed 5%, Pericarpium Citri Reticulatae 2%, Rhizoma Alpiniae Officinarum 12%, Fructus Evodiae 2%, Flos Caryophylli 4%, Cortex Cinnamomi 2%, Rhizoma Acori Graminei 1%, Borneolum Syntheticum 1%.
Embodiment three:
Herba Pogostemonis 4%, Herba Eupatorii 11%, Herba Taraxaci 11%, Herba Artemisiae Scopariae 3%, Rhizoma Atractylodis 1%, the Radix Stemonae 5%, Rhizoma Chuanxiong 3%, Rhizoma Curcumae 5%, Flos Carthami 2%, Radix Salviae Miltiorrhizae 5%, Radix Angelicae Sinensis 5%, Radix Curcumae 1%, Rhizoma Corydalis 5%, Rhizoma Curcumae Longae 1%, Herba Artemisiae Anomalae 3%, the Radix Aucklandiae 5%, Fructus Amomi 5%, Pericarpium Citri Reticulatae Viride 2%, roud cardamon seed 3%, Pericarpium Citri Reticulatae 3%, Rhizoma Alpiniae Officinarum 6%, Fructus Evodiae 2%, Flos Caryophylli 3%, Cortex Cinnamomi 5%, Rhizoma Acori Graminei 1%, Borneolum Syntheticum 2%.
Embodiment four:
Herba Pogostemonis 11%, Herba Eupatorii 11%, Herba Taraxaci 11%, Herba Artemisiae Scopariae 11%, Rhizoma Atractylodis 11%, the Radix Stemonae 11%, Rhizoma Chuanxiong 1%, Rhizoma Curcumae 1%, Flos Carthami 1%, Radix Salviae Miltiorrhizae 1%, Radix Angelicae Sinensis 1%, Radix Curcumae 1%, Rhizoma Corydalis 1%, Rhizoma Curcumae Longae 1%, Herba Artemisiae Anomalae 2%, the Radix Aucklandiae 2%, Fructus Amomi 2%, Pericarpium Citri Reticulatae Viride 2%, roud cardamon seed 2%, Pericarpium Citri Reticulatae 2%, Rhizoma Alpiniae Officinarum 2%, Fructus Evodiae 2%, Flos Caryophylli 4%, Cortex Cinnamomi 4%, Rhizoma Acori Graminei 2%, Borneolum Syntheticum 2%.
Embodiment five:
Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae each 1%, Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae each 2%, Radix Angelicae Sinensis 3%, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae each 1%, Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae each 5%, Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi each 12%, Rhizoma Acori Graminei, Borneolum Syntheticum 1%.
Embodiment six:
Herba Pogostemonis 14%, Herba Eupatorii 15%, Herba Houttuyniae 12%, Rhizoma Atractylodis 8%, the Radix Stemonae 16.5%, Rhizoma Chuanxiong 1%, Rhizoma Curcumae 2%, Flos Carthami 2%, the Herba Lycopi 1%, Radix Angelicae Sinensis 2%, Herba Artemisiae Anomalae 2%, Fructus Amomi 2%, Pericarpium Citri Reticulatae Viride 4%, roud cardamon seed 2%, Rhizoma Alpiniae Officinarum 4%, Fructus Evodiae 6.5%, Flos Caryophylli 2%, Borneolum Syntheticum 4%.
Embodiment seven:
Herba Eupatorii, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae each 1.5%, Flos Carthami 1%, Radix Salviae Miltiorrhizae 3%, Radix Curcumae 1%, Rhizoma Corydalis 1%, Rhizoma Curcumae Longae 8%, the Radix Aucklandiae 7.5%, Pericarpium Citri Reticulatae 7.5%, Herba Artemisiae Anomalae 7.5%, Fructus Amomi 7.5%, Fructus Evodiae 24%, Ramulus Cinnamomi 24%, Rhizoma Acori Graminei 2%.
Embodiment eight:
Herba Pogostemonis 16.5%, Herba Taraxaci 10%, Herba Artemisiae Scopariae 16.5%, Rhizoma Atractylodis 7%, Rhizoma Chuanxiong 8%, the Herba Lycopi 4%, Radix Angelicae Sinensis %, Rhizoma Corydalis 2%, Rhizoma Curcumae Longae 1%, Fructus Evodiae 3%, Flos Caryophylli 5%, Rhizoma Acori Graminei 3%, Borneolum Syntheticum 1%, Pericarpium Citri Reticulatae Viride 7.5%, roud cardamon seed 4%, Fructus Amomi 3.5%, Pericarpium Citri Reticulatae 7%.
Embodiment nine:
Herba Pogostemonis 7%, Herba Eupatorii 7%, Herba Houttuyniae 5%, Herba Artemisiae Scopariae 5%, Rhizoma Atractylodis 16.5%, the Radix Stemonae 3%, Flos Carthami 8%, the Herba Lycopi 3%, Radix Angelicae Sinensis 7%, Radix Curcumae 8%, Rhizoma Corydalis 7%, Herba Artemisiae Anomalae 1%, the Radix Aucklandiae 1%, Pericarpium Citri Reticulatae Viride 1%, roud cardamon seed 6%, Fructus Evodiae 8%, Ramulus Cinnamomi 4%, Borneolum Syntheticum 2.5%.
Embodiment ten:
Herba Pogostemonis 2%, Herba Taraxaci 3%, Herba Houttuyniae 2%, Herba Artemisiae Scopariae 7%, the Radix Stemonae 3%, Rhizoma Chuanxiong 4%, Rhizoma Curcumae 8%, Flos Carthami 3%, Radix Salviae Miltiorrhizae 8%, Radix Angelicae Sinensis 5%, Radix Curcumae 3%, Rhizoma Corydalis 4%, Rhizoma Curcumae Longae 5%, Herba Artemisiae Anomalae 4%, the Radix Aucklandiae 4%, Fructus Amomi 1%, Pericarpium Citri Reticulatae 1%, Rhizoma Alpiniae Officinarum 19%, Fructus Evodiae 7%, Flos Caryophylli 1%, Cortex Cinnamomi 1%, Ramulus Cinnamomi 1%, Rhizoma Acori Graminei 2%, Borneolum Syntheticum 2%.
Embodiment 11
Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae, Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi each 5%, Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae, Pericarpium Citri Reticulatae, roud cardamon seed, Pericarpium Citri Reticulatae Viride, Fructus Amomi, the Radix Aucklandiae, Herba Artemisiae Anomalae each 3.33%, Rhizoma Acori Graminei, Borneolum Syntheticum each 1.69%.
Claims (13)
1, a kind of medicine for external use for the treatment of hepatopathy is characterized in that being made up of antipyretic and antidotal type Chinese medicine, invigorating blood circulation what class Chinese medicine, liver-smoothing, qi-regulating class Chinese medicine, warming YANG class Chinese medicine, the class of having one's ideas straightened out Chinese medicine.
2, medicine for external use according to claim 1 is characterised in that by weight, and described antipyretic and antidotal type Chinese medicine accounts for 6-66%, and invigorating blood circulation what class Chinese medicine accounts for 8-40%, and liver-smoothing, qi-regulating class Chinese medicine accounts for 12-30%, and warming YANG class Chinese medicine accounts for 8-48%, and the class of having one's ideas straightened out Chinese medicine accounts for 2-4%.
3, according to claim 1,2 described medicine for external use, the preferred value that is characterised in that each constituent is: antipyretic and antidotal type Chinese medicine 18-42%, and invigorating blood circulation what class Chinese medicine accounts for 8-40%, and liver-smoothing, qi-regulating class Chinese medicine accounts for 12-30%, warming YANG class Chinese medicine accounts for 12-28%, and the class of having one's ideas straightened out Chinese medicine accounts for 2-4%.
4, medicine for external use according to claim 1 is characterised in that antipyretic and antidotal type Chinese medicine can select the 4-6 kind from following Chinese medicine: Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci or Herba Houttuyniae, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae.
5, according to claim 1,4 described medicine for external use, be characterised in that antipyretic and antidotal type Chinese medicine is made up of Herba Pogostemonis, Herba Eupatorii, Herba Taraxaci or Herba Houttuyniae, Herba Artemisiae Scopariae, Rhizoma Atractylodis, the Radix Stemonae, each Chinese medicine accounts for the 1-11% of described medicine for external use gross weight, and the best is 3-7%.
6, medicine for external use according to claim 1 is characterised in that invigorating blood circulation what class Chinese medicine can select the 5-8 kind from following Chinese medicine: Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae or Herba Lycopi, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae.
7, according to claim 1,6 described medicine for external use, be characterised in that invigorating blood circulation what class Chinese medicine is made up of Rhizoma Chuanxiong, Rhizoma Curcumae, Flos Carthami, Radix Salviae Miltiorrhizae or Herba Lycopi, Radix Angelicae Sinensis, Radix Curcumae, Rhizoma Corydalis, Rhizoma Curcumae Longae, each Chinese medicine accounts for the 1-5% of described medicine for external use gross weight.
8, medicine for external use according to claim 1 is characterised in that liver-smoothing, qi-regulating class Chinese medicine can select the 4-6 kind from following Chinese medicine: Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae.
9, according to claim 1,8 described medicine for external use, be characterised in that liver-smoothing, qi-regulating class Chinese medicine is made up of Herba Artemisiae Anomalae, the Radix Aucklandiae, Fructus Amomi, Pericarpium Citri Reticulatae Viride, roud cardamon seed, Pericarpium Citri Reticulatae, each Chinese medicine accounts for the 2-5% of described medicine for external use gross weight.
10, medicine for external use according to claim 1 is characterised in that warming YANG class Chinese medicine can select the 2-4 kind from following Chinese medicine: Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi or Ramulus Cinnamomi.
11, according to claim 1,10 described medicine for external use, be characterised in that warming YANG class Chinese medicine is made up of Rhizoma Alpiniae Officinarum, Fructus Evodiae, Flos Caryophylli, Cortex Cinnamomi or Ramulus Cinnamomi, each Chinese medicine accounts for the 2-12% of described medicine for external use gross weight, and the best is 3-7%.
12, medicine for external use according to claim 1 is characterised in that the class Chinese medicine of having one's ideas straightened out can select the 1-2 kind from following Chinese medicine: Rhizoma Acori Graminei, Borneolum Syntheticum.
13, according to claim 1,12 described medicine for external use, be characterised in that the class Chinese medicine of having one's ideas straightened out is made up of Rhizoma Acori Graminei, Borneolum Syntheticum, each Chinese medicine accounts for the 1-2% of described medicine for external use gross weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110361 CN1041495C (en) | 1993-04-02 | 1993-04-02 | External application medicine for curing hepatic disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93110361 CN1041495C (en) | 1993-04-02 | 1993-04-02 | External application medicine for curing hepatic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1078905A true CN1078905A (en) | 1993-12-01 |
| CN1041495C CN1041495C (en) | 1999-01-06 |
Family
ID=4988234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93110361 Expired - Fee Related CN1041495C (en) | 1993-04-02 | 1993-04-02 | External application medicine for curing hepatic disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1041495C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435395A (en) * | 2014-10-28 | 2015-03-25 | 王铁创 | Externally applied traditional Chinese medicine composition for treating hepatic disease and delivery way thereof |
| CN104940848A (en) * | 2015-07-25 | 2015-09-30 | 孙振玲 | Medicine for treating hepatic encephalopathy |
| CN108653660A (en) * | 2018-07-26 | 2018-10-16 | 谢良才 | A kind of drug for treating alcoholic liver, fatty liver |
| CN110201063A (en) * | 2019-07-04 | 2019-09-06 | 姜鹏凌 | A kind of Chinese medicine composition for treating liver function detraction |
| CN112402577A (en) * | 2020-12-01 | 2021-02-26 | 孔令玉 | Traditional Chinese medicine composition for liver space occupying venereal disease and interventional operation and preparation method thereof |
| CN115998831A (en) * | 2023-02-11 | 2023-04-25 | 甘肃中医药大学 | Traditional Chinese medicine composition for treating non-alcoholic steatohepatitis |
-
1993
- 1993-04-02 CN CN 93110361 patent/CN1041495C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435395A (en) * | 2014-10-28 | 2015-03-25 | 王铁创 | Externally applied traditional Chinese medicine composition for treating hepatic disease and delivery way thereof |
| CN104940848A (en) * | 2015-07-25 | 2015-09-30 | 孙振玲 | Medicine for treating hepatic encephalopathy |
| CN108653660A (en) * | 2018-07-26 | 2018-10-16 | 谢良才 | A kind of drug for treating alcoholic liver, fatty liver |
| CN110201063A (en) * | 2019-07-04 | 2019-09-06 | 姜鹏凌 | A kind of Chinese medicine composition for treating liver function detraction |
| CN112402577A (en) * | 2020-12-01 | 2021-02-26 | 孔令玉 | Traditional Chinese medicine composition for liver space occupying venereal disease and interventional operation and preparation method thereof |
| CN115998831A (en) * | 2023-02-11 | 2023-04-25 | 甘肃中医药大学 | Traditional Chinese medicine composition for treating non-alcoholic steatohepatitis |
| CN115998831B (en) * | 2023-02-11 | 2023-10-10 | 甘肃中医药大学 | Traditional Chinese medicine composition for treating non-alcoholic steatohepatitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1041495C (en) | 1999-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN102210844B (en) | Chinese medicinal composition for treating chronic hepatitis and preparation method thereof | |
| CN1086429A (en) | The compound method of hard paralysed health | |
| CN101829274B (en) | Medicament for treating liver disease | |
| CN1092314A (en) | Treatment diarrheal Chinese medicine for outer use | |
| CN101214304A (en) | Chinese medicine prescription for treating chronic cholecystitis | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1041495C (en) | External application medicine for curing hepatic disease | |
| CN1130219C (en) | Litholysizing bear gall powder | |
| CN1100642A (en) | Traditional Chinese medicine prepn. for curing B-hepatitis | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1333026A (en) | Medicine for treating hyperplasia of mammary glands | |
| CN1935211B (en) | Medicinal composition for treating cerebral ischemia | |
| CN1589839A (en) | Stasis transforming pain relieving particle agent and its preparation method | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN111773292B (en) | Traditional Chinese medicine composition for treating herpes zoster as well as preparation method and application thereof | |
| CN101897920A (en) | Chinese medicinal preparation for treating infertility | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN101352496A (en) | Chinese medicine for treating hepatitis | |
| CN1161135C (en) | Medicine for curing carcinoma of stomach | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN1094355C (en) | Yugan pill for curing hepatitis and ascites due to cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |